Opsoclonus-myoclonus Syndrome in an Adult with Malignant Melanoma

Overview

Journal J Neurol

Specialty Neurology

Date 2006 May 23

PMID 16715202

Citations 9

Authors

K-Y Jung

J Youn

C-S Chung

Affiliations

Soon will be listed here.

Citing Articles

Paraneoplastic syndromes in patients with melanoma.

Dec M, Arasiewicz H Postepy Dermatol Alergol. 2024; 41(3):251-261.

PMID: 39027696 PMC: 11253314. DOI: 10.5114/ada.2024.141114.

Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review.

Norrito R, Puleo M, Pintus C, Basso M, Rizzo G, Di Chiara T Brain Sci. 2024; 14(2).

PMID: 38391750 PMC: 10887192. DOI: 10.3390/brainsci14020176.

Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.

Bartley C, Ngo T, Do L, Zekeridou A, Dandekar R, Muniz-Castrillo S Ann Neurol. 2023; 94(6):1086-1101.

PMID: 37632288 PMC: 10842626. DOI: 10.1002/ana.26776.

Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.

Reinecke R, Reilander A, Seiler A, Koch C, Voss M BMC Neurol. 2022; 22(1):507.

PMID: 36581905 PMC: 9801616. DOI: 10.1186/s12883-022-03012-6.

New-Onset Refractory Status Epilepticus (NORSE) as a Recurrence of Anti-Neuronal Nuclear Antibody 2 (ANNA-2) Encephalitis After Immune Checkpoint Inhibition Therapy.

Pitter D, Mejico L, Latorre J, Cuello-Oderiz C Cureus. 2021; 13(6):e16074.

PMID: 34345555 PMC: 8324427. DOI: 10.7759/cureus.16074.

References

Bataller L, Graus F, Saiz A, Vilchez J . Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001; 124(Pt 2):437-43. DOI: 10.1093/brain/124.2.437. View

Graus F, Delattre J, Antoine J, Dalmau J, Giometto B, Grisold W . Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004; 75(8):1135-40. PMC: 1739186. DOI: 10.1136/jnnp.2003.034447. View

Rees J . Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry. 2004; 75 Suppl 2:ii43-50. PMC: 1765657. DOI: 10.1136/jnnp.2004.040378. View

Honnorat J, Cartalat-Carel S . Advances in paraneoplastic neurological syndromes. Curr Opin Oncol. 2005; 16(6):614-20. DOI: 10.1097/01.cco.0000142486.89472.eb. View

Berger J, Mehari E . Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma. J Neurooncol. 1999; 41(1):43-5. DOI: 10.1023/a:1006189210197. View